Cargando…
Implementation of an Opioid and Benzodiazepine Deprescribing Program for Older Adults in an Outpatient Setting
The United States spends $50 billion each year on 2.8 million injuries and 800,000 hospitalizations older adults (age 65 years and older) incur as the result of falls. Chronic use of central nervous system (CNS)-active medications, such as opioid and/or benzodiazepine (BZD) medications, increases th...
Autores principales: | Armistead, Lori, Busby-Whitehead, Jan, Ferreri, Stefanie, Henage, Cristine, Hughes, Tamera, McBride, Jack, Roberts, Ellen, Urick, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7742048/ http://dx.doi.org/10.1093/geroni/igaa057.3334 |
Ejemplares similares
-
Exploration of Barriers and Facilitators for Deprescribing Opioids and Benzodiazepines to Reduce Older Adult Falls
por: Roberts, Ellen, et al.
Publicado: (2020) -
Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
por: Niznik, Joshua D., et al.
Publicado: (2022) -
A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial
por: Niznik, Joshua, et al.
Publicado: (2022) -
Transitioning Focus Group Research to a Videoconferencing Environment: A Descriptive Analysis of Interactivity
por: Henage, Cristine B., et al.
Publicado: (2021) -
FACTORS FACILITATING COLLABORATION AND ENGAGEMENT: BUILDING AND SUSTAINING STATEWIDE COALITIONS
por: Henage, Cristine B, et al.
Publicado: (2019)